Docoh
Loading...

CVV CVD Equipment

Filed: 9 Mar 21, 4:05pm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported):

March 5, 2021

 

CVD EQUIPMENT CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 

New York

 

1-16525

 

11-2621692

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission File Number)

 

(IRS Employer Identification

No.)

 

355 South Technology Drive

Central Islip, New York

 

11722

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (631) 981-7081

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities Registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock

CVV

NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On March 5, 2021, the Board of Directors (the “Board”) of CVD Equipment Corporation (the “Company”) elected Dr. Robert M. Brill to serve as a director of the Company, expanding its Board to six directors, effective as of March 6, 2021. Dr. Brill had previously served on the Company’s Board from April 2018 until October 2019, at which time he stepped down for personal reasons.

 

Dr. Brill was co-founder and managing partner of Newlight Management, which managed venture capital funds that focused on early stage technology companies. Prior to co-founding Newlight, Dr. Brill was a general partner of Poly Ventures, a Long Island based venture capital fund. Dr. Brill is a member of the Board of Directors of the L.I. Angel Network, the L.I. High Tech Incubator and several private companies. Dr. Brill has also previously served on the Board of Directors of multiple public and private companies. Dr. Brill served as General Manager of Harris Corporation’s CMOS Semiconductor Division. He also held various technical and management positions at IBM’s semiconductor operation. Dr. Brill holds a Ph.D in nuclear physics from Brown University and a B.A. and a B.S. in Engineering Physics from Lehigh University.

 

There is no arrangement or understanding between Dr. Brill and any other persons pursuant to which Dr. Brill was elected as a director. The Company believes that Dr. Brill is qualified to serve as a director of the Company because of his extensive background and experience serving and advising technology companies.

 

Dr. Brill will receive compensation as a director in accordance with the Company’s Director Compensation Plan applicable to all non-employee directors described in the Company’s Report on Form 8-K filed with the U.S. Securities and Exchange Commission on February 28, 2019.

 

Item 8.01

Other Events.

 

On March 9, 2021, the Company issued a press release reporting the appointment of Dr. Brill as a director. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

 

Item 9.01

Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No.         Description

 

99.1                      Press Release dated March 9, 2021.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date:  March 9, 2021

 

 

CVD EQUIPMENT CORPORATION

   
 

By:

/s/ Thomas McNeill

 

Name: 

Thomas McNeill

 

Title: 

Chief Financial Officer and

Secretary